| Title | Retention on buprenorphine is associated with high levels of maximal viral suppression among HIV-infected opioid dependent released prisoners. |
| Publication Type | Journal Article |
| Year of Publication | 2012 |
| Authors | Springer, Sandra A., Jingjun Qiu, Ali Shabahang Saber-Tehrani, and Frederick L. Altice |
| Journal | PloS one |
| Volume | 7 |
| Issue | 5 |
| Pagination | e38335 |
| Date Published | 2012 |
| ISSN | 1932-6203 |
| Keywords | Adult, Buprenorphine, Female, HIV Infections, Humans, Male, Middle Aged, Naloxone, Opioid-Related Disorders, Prisoners, Prospective Studies, Treatment Outcome |
| Abstract | HIV-infected prisoners lose viral suppression within the 12 weeks after release to the community. This prospective study evaluates the use of buprenorphine/naloxone (BPN/NLX) as a method to reduce relapse to opioid use and sustain viral suppression among released HIV-infected prisoners meeting criteria for opioid dependence (OD). |
| DOI | 10.1371/journal.pone.0038335 |
| Alternate Journal | PLoS ONE |
